Received Apr 2, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | — | — |
neuropathy in hands and arms; Body aches; could not walk following second dose.; 168 inflammation score.; This is a spontaneous report received from a Consumer or other non HCP. A 62-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), in Dec2020 as dose 2, single (Batch/Lot number: unknown), in arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, SINGLE, Manufacture: Unknown, Lot: Unknown), for COVID-19 Immunization. The following information was reported: INFLAMMATION (disability) with onset Dec2020, outcome "recovered with sequelae", described as "168 inflammation score."; MYALGIA (disability) with onset Dec2020, outcome "recovered with sequelae", described as "Body aches"; GAIT INABILITY (disability) with onset Dec2020, outcome "recovered with sequelae", described as "could not walk following second dose."; NEUROPATHY PERIPHERAL (disability) with onset Dec2020, outcome "recovered with sequelae", described as "neuropathy in hands and arms". The patient underwent the following laboratory tests and procedures: inflammation score.: (Dec2020) 168. It was unknown if therapeutic measures were taken as a result of neuropathy peripheral, myalgia, gait inability, inflammation. Batch/lot number is not provided, and it cannot be obtained.
Test Date: 202012; Test Name: inflammation score.; Result Unstructured Data: Test Result:168